(a) Developing a list of objective and definable serious adverse events to be reported by participants. In developing this list, the board shall consider similar lists developed in other states and nationally. The board may change the list from time to time.
(b) Developing a budget.
(c) Establishing a process to seek grants and other funding from federal and other sources.
(d) Establishing a method to determine participant fees, if necessary.
(e) Establishing auditing and oversight procedures, including a process to:
(A) Assess completeness of reports from participants;
(B) Assess credibility and thoroughness of root cause analyses submitted to the program;
(C) Assess the acceptability of action plans and participant follow-up on the action plan; and
(D) Obtain certification by the Public Health Officer on the completeness, credibility, thoroughness and acceptability of participant reports, root cause analyses and action plans.
(f) Establishing criteria for terminating a participant from the program. Incomplete reporting, failure to comply with ORS 442.837 (4) or failure to adequately implement an action plan are grounds for termination from the program.
(2) The board may not use or disclose patient safety data reported, collected or developed pursuant to ORS 442.819 to 442.851 for purposes of any enforcement or regulatory action in relation to a participant.
(3) The board shall maintain the confidentiality of all patient safety data that identifies or could be reasonably used to identify a participant or an individual who is receiving or has received health care from the participant. [2003 c.686 §9; 2011 c.30 §3]
Note: See note under 442.819.